CA2044043C - Process for the production of rapidly disintegrating sheet-like presentations - Google Patents

Process for the production of rapidly disintegrating sheet-like presentations

Info

Publication number
CA2044043C
CA2044043C CA002044043A CA2044043A CA2044043C CA 2044043 C CA2044043 C CA 2044043C CA 002044043 A CA002044043 A CA 002044043A CA 2044043 A CA2044043 A CA 2044043A CA 2044043 C CA2044043 C CA 2044043C
Authority
CA
Canada
Prior art keywords
composition
sheet
process according
film
forming agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002044043A
Other languages
French (fr)
Other versions
CA2044043A1 (en
Inventor
Michael Horstmann
Wolfgang Laux
Stefan Hungerbach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of CA2044043A1 publication Critical patent/CA2044043A1/en
Application granted granted Critical
Publication of CA2044043C publication Critical patent/CA2044043C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/50Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by shape, structure or physical form, e.g. products with supported structure
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/343Products for covering, coating, finishing, decorating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208Tissues; Wipes; Patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G2200/00COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
    • A23G2200/06COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents containing beet sugar or cane sugar if specifically mentioned or containing other carbohydrates, e.g. starches, gums, alcohol sugar, polysaccharides, dextrin or containing high or low amount of carbohydrate
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G2210/00COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing inorganic compounds or water in high or low amount

Abstract

A presentation which, in the form of a film, permits the individual dosage of drugs, confectionary, other food, cosmetics and the like for oral application or intake. The presentation is characterized by the fact that it comprises a mass of 20 to 60%-wt. of at least a film former, 2 to 40X-wt. of at least a gel former, 0.1 to 35%-wt. of at least an active substance, and up to 40%-wt. of an inert filling agent, being applied on a carrier, or by consisting of a mass having the aforementioned composition but is unsupported. In the production thereof, an intimate mixture of said components is prepared, optionally with the addition of up to 30%-wt. of a polar solvent, and processed to form a homogeneous, spreadable or extrudable mass.

Description

204404~

The present invention relates to sheet-like forms of administration of drugs, confectionary, other food, cosmetics and the like for oral application or intake.

Presentations of drugs, sweets and other foodstuff, as well as cosmetics which are to be applied in the oral region or have to be taken by deglutition, in princi-ple, can either be freely dosed by the applicant or are already pre-divided into dosage units by the manu-facturer. Such prepared forms are particularly common in pharmaceutics in the form of tablets, capsules, coated tablets, pills, vials and the like. Compared to dropping-solutions, ointments, or creams which have to be dosed by the user, unintentional wrong dosage by applicant is avoided in these cases.

From the application technological point of view, tab-lets must have a certain minimum size (5 to 6 mm diam-eter) and a certain minimum weight (approximately 100 to 200 mg), in order to ease handling of these presen-tations. Thus, highly efficacious drugs may contain about 99% of inactive ingredients, relative to the tablet weight.

20~gQ~3 Even foodstuff, in particular confectionary, is fre-quently found on the market in individually dosed form ~candies, sweetener tablets, peppermint lozenges, etc.). In this case too - for instance as regards can-dies - there is the wish to achieve the desired sensa-tion of taste using less "adjuvants" (here usually sugar).

For this reason many technical proposals have been made recently; they are aiming at a reduction of the amount of inactive ingredients in presentations and, at the same time, ensuring safe handling of these sub-stances.

A proposal of particular interest in this connection is the production of sheet-like active substance car-riers, e.g., as disclosed by DE 35 34 983, DE 27 46 414, BE 637 363, DE 24 32 925, or DE 36 30 603.

According to the known production processes such pa-per-like carriers are manufactured without any active substance first, and they are then sprayed (e.g. GB 1 061 557) with an active substance-containing solution or coated/printed with an active substance-containing layer of higher concentration (e.g. EP 0 219 762).

204404~

However, common complete or partial dissolution of ac-tive and inactive substances in water or other sol-vents (DE 24 49 865) followed by spreading - or cast-ing (e.g. JP 69026674) - and drying may be expected to be the process of choice for the skilled artisan. Ex-trusion under the action of heat was also proposed (Research Disclosure, 1986, No. 263, March, 145 to 146 (No. 26341).

Film-like presentations offer a great variety of pos-sibilities to separate the individual doses. They can be imagined to have the form of sheets of stamps in which the portion is taken out of the complete compos-ite only a short time prior to use (e.g. BE 637 363, EP 0 219 762). Individual doses of different size can be offered on a tape-like presentation as well, e.g., separated by perforation (e.g. DE 27 46 414). In particular when an inedible carrier is used (e.g. DE
36 30 603), complete separation into individual por-tions is indicative; this permits a more hygienic, comfortable, and safe removal.

Although a number of flat-shaped forms of administra-tion and processes for the production thereof are known in the art, there still is a considerable lack as to the galenic composition, i.e., the selection of adjuvants, and as to the conception of the physico-chemical fine structure of such sheet-like carriers.
Many purposes and aims have to be taken into consid-eration: Rapid disintegration is required for many drugs to allow rapid swallowing of the dosage unit;
other circumstances, in turn, require that the drug temporarily sticks on the mucous membrane of the mouth, and in other occasions - e.g., in case of a medicinal agent with short-time action - a consider-ably retarded disintegration is desired. In case of sweets, a medium retention time in the mouth, e.g., of flavoring substances, will in general be desirable.
Cosmetic, film-like toothpastes should be flexible and disintegrate as soon as possible. In general, sheet-like presentations may not be too fragile so as to ensure safe transfer of the portions to the place of destination. If a carrier is used, both materials must have an adhesion behavior exactly adapted to each oth-er; this is for two reasons: on the one hand, the sep-aration of the doses, e.g., by means of partial punch-ing and peeling off the partitioning inserts, is en-sured during production, and, on the other hand, the bond to the carrier is effected even during storage.
If drying is required during the production, it should be possible to render the formulation spreadable with the least possible solvent proportion (preferably 20~043 water) so that the energy involved during drying may be maintained as low as possible.

The galenic compositions known until today, do not satisfy these requirements. Basic principles of the tablet technology are described in connection with film-like tapes by DE 27 46 414; that is the use of optionally thermoplastic binders and other auxiliary agents, the chemical cross-linking, or the addition of hydrophobic substances to delay the disintegration, the combination of several layers and the use of mi-cro-encapsulated active substances. Conventional tab-let-disintegrants are used therein as disintegration auxiliaries for films. According to our own findings, the proposals cannot cope with the new pharmaceutic products. The classic disintegrants require a porous, mechanically stable surrounding created by bonding forces between the particles, if they are to cause disintegration through swelling by water addition, or by stored Hooke's deformation energy.
However, these preconditions do not exist in case of sheet-like presentations which always remain slightly flexible and are of low porosity. Swelling particles may even delay the disintegration of the films due to withdrawal of water.

According to DE 24 32 925 a formulation contains wa-ter-soluble cellulose ethers and separating agents and, optionally, fillers. Since, however, a predomi-nating portion of water-soluble polymers always re-quires the addition of a large amount of water to achieve a sufficiently low viscosity of the mass being ready to spread or cast, this structure involves high drying cost during fabrication.

In addition, the adhesive bond to the base is affected due to such an extreme material shrinkage.
When sheet-like forms of applications are produced by spreading water-base masses to a paper or film which were rendered dehesive, the liquid readily drops-off the support or at least forms zones of different film thicknesses due to the surface tension. Although the viscosity may be increased by adding cellulose deriv-ativesJ etc., spreading through the small gap will be-come more difficult.

According to other sources (e.g., DE 35 34 981, DE 36 30 603) viscosity formers are therefore preferred;
they result in low-viscosity solutions in the heat (in the coating machine), immediately afterwards, however, provide gel-like, stabilized films on cooling, which then perfectly dry in the air, e.g., agar-agar or gel-atin. However, this method cannot satisfy because dry-20440~3 ing does not permit the application of high tempera-tures since the mass drops-off again. The drying of such wet masses at low temperatures is uneconomic due to the long dwell times in the apparatus.

It was accordingly the object of the present invention to provide a sheet-like, individually dosed presenta-tion which rapidly disintegrates in water. It was a further object of the present invention to provide a process for the production of such presentations. This process requires only a very small amount of water for processing to achieve sufficient fluidity for dosage by means of knife or roll coating procedures but nev-ertheless provides a film of uniform thickness on a dehesive carrier; in dry condition good adherence to the carrier is achieved, at the same time, however, easy removal from the carrier, both during subsequent treatment, e.g., during separating by punching, and prior to application is possible.

This object is achieved according to the present in-vention by a presentation which in the form of a sheet permits single dosage of drugs, confectionary and oth-er food, cosmetics, and the like intended for oral ap-plication or intake, and which is characterized by the fact that it comprises a mass consisting of 20 to 60%-wt. of at least one film-formlng agent, 2 to 40%-wt. of at least one gel-forming agent, 0.1 to 35%-wt. of at least one active substance, and up to 40%-wt. of at least one inert filllng agent being applied on a carrier, or which is unsupported and consists of a mass having the aforementioned composition.
The object to provide a process for the production of such a form of administratlon was achleved by preparing an intimate mixture of the above mentioned components, optionally with adding up to 30%.wt of a polar solvent, and processing it to a homogeneous, spreadable or extrudable mass.
In this connection, the indications of the percentage by weight relate to the solvent-free mass of the four basic components.
Accordlng to one aspect of the present lnvention there is provided a composition in the form of a sheet of a drug, confectionary or other foodstuff, or cosmetic as active ingredient for oral application or intake, which rapldly disintegrates in water, comprising 20 to 60%-wt. of at least one film-forming agent, 2 to 40%-wt. of at least one gel-forming agent, 0.1 to 35%-wt.

of at least one said active ingredient and up to 40%-wt. of at least one inert filling agent, wherein the composition is adhered to a suitable support or is unsupported, the film forming agent substantially consists of a 8a mixture of a monomeric or oligomeric sugar or sugar derlvative of a sugar alcohol or polyethylene glycol, the gel forming agent is a polymeric carbohydrate or a derivative thereof, gelatin, a carboxyvinyl copolymer, a polyvinyl alcohol, or a mixture thereof, the filler is calcium carbonate, calcium sulfate, a calcium phosphate, a carbohydrate present in a crystalline or partially crystalline form, talc, titanium dioxide, zinc oxide, magnesium stearate, or a mixture thereof, and said active ingredient is a pharmacologically active compound.
According to a further aspect of the present invention there is provided a process for preparing a composition as defined above which comprises intimately mixing 20 to 60%-wt. of the film-forming agent, 2 to 40%-wt.
of the gel-forming agent, 0.1 to 35%-wt. of said active ingredient and at maximum 40%-wt. of the inert filler, processing the composition to form a homogeneous, spreadable or extrudable composition and forming the composition into a sheet.
In some preferred embodiments: the sheet thickness of the compositions is 0.003 to 4 mm, more preferably 20 to 400 ~m, particularly 70 to 150 ~m; the composition is applied to a release paper or release film; the composition is in the form of individually dosed portions; and the sheet comprises at least two active ingredient-containing layers.
Surprisingly, the formulations according to the present invention may be rendered spreadable by adding only a 8b small amount of a polar solvent. In contrast to the formulations known in the art, they result in uniform films on dehesive carrlers already ln cold condltlons. In drled condition, the products may be separated by punching them in such a way that the individual doses may remain on a common carrier already used for spreading and drying. The presentation according to the present invention completely disintegrates in the 20440~3 mouth within 10 minutes, and may exclusively be manu-factured of components admissible under the present German Law on Food Products.

Suitable fillers include carbonates, phosphates, sili-cates, sulfates, and oxides of the alkaline earth met-als, zinc oxide, silicas, cellulose and the deriva-tives thereof, talc or titanium dioxide; however, slightly soluble sugars or derivatives thereof, such as lactose, or starch derivatives, such as cyclodex-trins may be used as well, provided that they are present in the products in a substantially dissolved form so that they meet the mechanical properties of a filler.

The term film formers is to embrace ingredients, such as sugar, sugar alcohols and the derivatives thereof, e.g., cane sugar, sorbitol, mannitol, xylitol, glu-cose, fructose, lactose, galactose, low-molecular or-ganic acids, such as succinic acid, malic acid, or adipic acid, polyethylene glycol, or mixtures of these substances, for example, honey.

The third essential component according to the present invention is a gel former being swellable in water and which, in general, is composed on the basis of poly-meric carbohydrates, e. g., starch and the derivatives thereof, agar-agar, alginic acid, arabinogalactans, galactomannan, cellulose and the derivatives thereof, carrageen, dextran, tragacanth, and many gums of vegetable origin. However, synthetic polymers soluble or swellable in water may also be used according to the present invention, examples thereof include carboxyvinyl copolymers, polyvinyl-pyrrolidone, polyvinyl alcohol, polyacrylic acid, or polyacrylamide. Even polypeptides, such as gelatin, albumin, collagen, or eggwhite may be used.
A component acting as filler, the film former and the gel former are essential components giving the product the desired properties but only on the condition that when the quantity of formulation is determined they are processed commonly and in accordance with the individual substance properties. In this connection, a filler or an active agent acting as filler may be used.
The above-mentioned advantageous properties result, if certain intervals of mixture ratios are maintained: Of film former 20 to 60%-wt., of gel former 2 to 40%-wt.~ of active substance 0.1 to 35%-wt., and of filler up to 40%-wt.
2~140~

Processing may be conducted according to processes known to the skilled artisan.
In general, the starting components will be premixed in dry condition, and then they will be transformed to a spreadable consistency under stirring by adding a polar solvent in an amount not exceeding 30%-wt. The use of homogenizers to render the mixture more inti-mate, or the application of a vacuum to remove air bubbles may be useful.

Dispersing and grinding devices having floating grind-ing elements (ball mills) are preferred in this con-nection.
The application of heat may accelerate the dispersion process and provide the desired physicochemical prop-erty of the initial products, however, this depends on the special properties of the gel and film formers.
The addition of water may possibly be unnecessary, if the film-forming agent melts.
A superficially homogeneous spreadable or extrudable mass results.
Shaping in general is carried out by means of spread-ing/knife coating or extrusion processes in which the mass passes a gap of defined diameter, e.g., a slot die of an extruder, thus giving it the outer shape.

201~04~

If a solvent is still present, this is at least par-tially withdrawn in suitable drying devices known to the skilled artisan.

The product is advantageously dried on a carrier to which it sticks due to adhesion even after drying. If, due to process technology, it is not possible to achieve a sufficient thickness of the initial product, two or more layers may be laminated on top of each other by pressure and, if necessary, heat.

Division into the individual doses is effected by cut-ting, punching, embossing or similar processes pro-viding areas of defined size which are separated or separable. If drying is effected on a carrier, the presentation may remain on this carrier after said separation procedure until it is applied; this con-siderably eases taking it off.

The present invention will be illustrated in more de-tai1 by the following examples:

Example 1:

75 9 acetylated starch 62 9 honey 2~4404~

55 9 calcium sulfate dihydrate 5 g citric acid 50 9 water are mixed in a closed stirring apparatus and heated to 50OC. The mixture is homogenized under stirring for two hours and subsequently cooled to room temperature.
Stirring is continued for half an hour under vacuum and the evaporated water is added again.

2 ml of peppermint oil are added and incorporated by stirring over a 5-minute period.

The homogeneous mass is spread on siliconized paper with a coating device at a gap width of 500 ~m and dried at 80OC for 15 minutes.

Cuts outlining the later shape are inserted into the dried mass without damaging the paper carrier by means of suitable cutting devices. The material remaining between the obtained individually dosed presentations is removed in one process step by mechanical withdraw-al.

To protect the presentations from drying-up, groups of each 12 of them being placed on a common piece of pa-per carrier are sealed into a composite packaging ma-20~4~

terial of paper/aluminum/ethylenevinyl-acetate which is substantially impermeable to water vapor.

Use: flavor carrier (sweets) Example 2:

100 9 polyethylene glycol ~molecular weight approxi-mately 1,500 g/mol) 8 9 carboxyvinyl copolymer are kneaded until homogeneous in a heatable double-Z-kneader at 80~C (duration: 2 hours) 70 9 lactose are added and kneaded into the basic mass within 30 minutes. The temperature is reduced to 50~C.

8 9 glibenclamide are added; the preparation is kneaded for another 30-minute period. The hot mixture is filled into a plung-er-type extruder (available volume: approximately 150 ml) which has been pre-heated to 50~C. Extrusion is started immediately and at a conveyance speed of ap-204404~

proximately 10 g/min through a 10x1 mm sheet die;cooling until solidified on a cold, clean working sur-face. The resulting extrudate is divided into sections of 10 mm by means of a knife. An orally administrable form of a drug with approximately 3 mg of active sub-stance and a weight of approximately 80 mg results which disintegrates in the mouth.

ExamPle 3:

25 9 acetylated starch 20 9 sorbitol 30 9 calcium carbonate 1 9 titanium dioxide 22 9 water 8 9 glycerol are mixed in a closed stirring apparatus and heated to 50OC. The mixture is homogenized under stirring within two hours and subsequently cooled to room temperature.
Stirring is continued for half an hour under vacuum, the evaporated water is compensated. 0.5 ml of pepper-mint oil is added and homogeneously incorporated by stirring over a 5-minute period.

20~14043 The mass is spread on siliconized paper with a coating device at a gap width of 500 ~m and dried at 80~C for 10 minutes.

Cuts outlining the later shape are inserted into the dried mass without damaging the paper carrier by means of a suitable cutting device. The material remaining between the obtained individually dosed presentations is removed by mechanical peeling.
On the paper carrier each presentation is individually sealed into a paper/aluminum/ethylenevinylacetate-com-posite packaging material which is substantially im-permeable to water vapor.

Use: instant toothpaste Example 4:

600 9 acetylated starch 440 9 calcium sulfate dihydrate 40 9 citric acid are weighed into a porcelain ball mill provided with 10 grinding elements (diameter appr. 4 cm) and pre-mixed in dry condition in the closed mill at 10 rpm for 1 hour. A suspension of 17 20440~3 20 9 titanium dioxide in 550 9 water is added and the mixture agitated under the same con-ditions for one hour.

500 9 of honey are added. Homogenization is continued at 10 rpm for 2 hours. Finally, 16 ml of peppermint oil are added and rotation continued for 18 hours.
The further treatment of the mass thus obtained is effected as described for Example 1.

It is understood that the specification and examples are illustrative but not limitative of the present in-vention and that other embodiments within the spirit and scope of the invention will suggest themselves to those skilled in the art.

Claims (20)

1. A composition in the form of a sheet of a drug, confectionary or other foodstuff, or cosmetic as active ingredient for oral application or intake, which rapidly disintegrates in water, comprising 20 to 60%-wt. of at least one film-forming agent, 2 to 40%-wt. of at least one gel-forming agent, 0.1 to 35%-wt.
of at least one said active ingredient and up to 40%-wt. of at least one inert filling agent, wherein the composition is adhered to a suitable support or is unsupported, the film forming agent substantially consists of a mixture of a monomeric or oligomeric sugar or sugar derivative of a sugar alcohol or polyethylene glycol, the gel forming agent is a polymeric carbohydrate or a derivative thereof, gelatin, a carboxyvinyl copolymer, a polyvinyl alcohol, or a mixture thereof, the filler is calcium carbonate, calcium sulfate, a calcium phosphate, a carbohydrate present in a crystalline or partially crystalline form, talc, titanium dioxide, zinc oxide, magnesium stearate, or a mixture thereof, and said active ingredient is a pharmacologically active compound.
2. A composition according to claim 1 comprising a polar solvent added to render the composition flowable, which solvent is not removed during drying.
3. A composition according to claim 1 wherein the sheet thickness of the composition is 0.003 to 4 mm.
4. A composition according to claim 1 wherein the sheet thickness of the composition is 20 to 400 µm.
5. A composition according to claim 1 wherein the sheet thickness of the composition is 70 to 150 µm.
6. A composition according to claim 1 wherein the composition is applied to a release paper or to a release film.
7. A composition according to any one of claims 1 to 6, comprising at least two active ingredient-containing layers.
8. A composition according to any one of claims 1 to 6, in the form of individually dosed portions.
9. A process for preparing a composition according to claim 1 which comprises intimately mixing 20 to 60%-wt. of the film-forming agent, 2 to 40%-wt. of the gel-forming agent, 0.1 to 35%-wt. of said active ingredient and at maximum 40%-wt. of the inert filler, processing the composition to form a homogeneous, spreadable or extrudable composition and forming the composition into a sheet.
10. A process according to claim 9, further comprising adding, in an amount not exceeding 30%-wt., relative to the composition, a polar solvent to the mixture during said intimate mixing and at least partially removing the polar solvent in a drying step after forming the sheet of the composition under vacuum.
11. A process according to claim 9 wherein the spreadable composition is obtained without the addition of solvent and with a film-forming agent which melts at the processing temperature.
12. A process according to claim 9 wherein the mixture further includes a homogenizing agent during said processing to obtain the homogeneous, spreadable composition.
13. A process according to claim 9 wherein the mixing is effected in a ball mill.
14. A process according to claim 9 wherein the mixing is effected under vacuum.
15. A process according to any one of claims 9 to 14 further comprising the step of adhering the composition to a suitable support.
16. A process according to any one of claims 9 to 14 wherein the thickness of the sheet formed is 0.003 to 4 mm.
17. A process according to any one of claims 9 to 14 wherein the thickness of the sheet formed is 20 to 400 µm.
18. A process according to any one of claims 9 to 14 wherein the thickness of the sheet formed is 70 to 150 µm.
19. A process according to claim 9 wherein the sheet is formed by applying the composition to a release paper or release film.
20. A use of a composition as defined in any one of claims 1 to 6 as a pharmacodynamic or therapeutic agent in the treatment of human or animal disease, as a cosmetic, as a perfuming or flavouring agent, or in a herbal tea preparation.
CA002044043A 1990-06-07 1991-06-06 Process for the production of rapidly disintegrating sheet-like presentations Expired - Lifetime CA2044043C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4018247A DE4018247A1 (en) 1990-06-07 1990-06-07 MANUFACTURING METHOD FOR QUICK-DISINFITTING FILM-SHAPED PHARMACEUTICAL FORMS
DEP4018247.9-44 1990-06-07

Publications (2)

Publication Number Publication Date
CA2044043A1 CA2044043A1 (en) 1991-12-08
CA2044043C true CA2044043C (en) 1998-04-28

Family

ID=6407961

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002044043A Expired - Lifetime CA2044043C (en) 1990-06-07 1991-06-06 Process for the production of rapidly disintegrating sheet-like presentations

Country Status (9)

Country Link
US (1) US5629003A (en)
EP (1) EP0460588B1 (en)
JP (1) JP2559301B2 (en)
AT (1) ATE127016T1 (en)
CA (1) CA2044043C (en)
DE (2) DE4018247A1 (en)
DK (1) DK0460588T3 (en)
ES (1) ES2078994T3 (en)
GR (1) GR3018233T3 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10301575B2 (en) 2015-04-14 2019-05-28 The Procter & Gamble Company Consumer product composition comprising a polyethylene glycol carrier with silicone particles dispersed therein
US10329519B2 (en) 2016-10-19 2019-06-25 The Procter & Gamble Company Consumer product composition comprising a polyethyleneglycol carrier, silicone conditioner, and particulate spacer material

Families Citing this family (165)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4416927C1 (en) * 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Device for release of active agents from melt-type adhesive
DE4419824A1 (en) * 1994-06-07 1995-12-14 Lohmann Therapie Syst Lts Volume-expandable, flat application form suitable as an active ingredient carrier, in particular for oral use
CA2206691A1 (en) * 1994-12-05 1996-06-13 Shintaro Tashiro Method of drug delivery and coatings for use in the method
DE19500977C2 (en) * 1995-01-14 1999-01-07 Lohmann Therapie Syst Lts Solid drug form with active ingredient distributed in polymeric material
DE19503336C2 (en) * 1995-02-02 1998-07-30 Lohmann Therapie Syst Lts Pharmaceutical form for delivering active substances to wounds, process for their preparation and their use
DE19508029C2 (en) * 1995-03-07 1997-10-09 Richard Prof Dr Sueverkruep Dosage form for external application of ophthalmic medicinal substances and method for the production thereof
DE19646392A1 (en) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Preparation for use in the oral cavity with a layer containing pressure-sensitive adhesive, pharmaceuticals or cosmetics for dosed delivery
DE19652257A1 (en) * 1996-12-16 1998-06-18 Lohmann Therapie Syst Lts Individually dosed, film-like dosage form that quickly disintegrates on contact with liquid and contains active ingredients and especially flavorings
US6096328A (en) * 1997-06-06 2000-08-01 The Procter & Gamble Company Delivery system for an oral care substance using a strip of material having low flexural stiffness
DE19745208A1 (en) * 1997-10-13 1999-04-15 Labtec Gmbh Pharmaceutical film that dissolves in mouth
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
AU760065B2 (en) 1998-04-27 2003-05-08 Larex, Inc. Derivatives of arabinogalactan and compositions including the same
US20030206942A1 (en) * 1998-09-25 2003-11-06 Neema Kulkarni Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent
US20030211136A1 (en) * 1998-09-25 2003-11-13 Neema Kulkarni Fast dissolving orally consumable films containing a sweetener
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
DE19856101A1 (en) * 1998-12-04 2000-06-08 Labtec Gmbh Patch for local administration of drugs in the oral cavity includes a drug-containing matrix comprising a water-insoluble cellulose ether and a water-soluble cellulose ether in a defined ratio
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
GB9901819D0 (en) * 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6800329B2 (en) * 1999-02-12 2004-10-05 Lts Lohmann Therapie-Systeme Ag Method for producing film-type dosage
CA2373983C (en) 1999-07-02 2007-11-13 The Procter & Gamble Company Systems comprising organosiloxane resins for delivering oral care substances and for prolonging such delivery
US6500462B1 (en) * 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
JP2003516357A (en) * 1999-12-09 2003-05-13 ワイカトリンク リミテッド Honey-based medical dressing
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
IT1318597B1 (en) * 2000-06-23 2003-08-27 A C R Applied Coating Res S A USE OF A HIGH CONTENT OF EPREGELATINIZED ACETYLATED AMYLOSE.
DE10034491A1 (en) * 2000-07-15 2002-01-24 Scs Skin Care Systems Gmbh Foil dermatics
TR200300731T2 (en) 2000-11-28 2004-08-23 Fmc Corporation Composition of edible PGA coating
DE10107659B4 (en) * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhesive disintegratable drug preparation for drug administration in veterinary and human medicine
US20030068376A1 (en) * 2001-04-20 2003-04-10 Lavipharm Laboratories Inc. Intraoral delivery of nicotine for smoking cessation
EP1391212A4 (en) * 2001-04-24 2008-09-03 Lintec Corp Oral preparations and supports for oral preparations
US8268333B2 (en) 2001-04-24 2012-09-18 Lintec Corporation Orally administered agent and an orally administered agent/supporting substrate complex
US6509040B1 (en) 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
US20070154527A1 (en) * 2001-10-12 2007-07-05 Monosoirx, Llc Topical film compositions for delivery of actives
US8663687B2 (en) 2001-10-12 2014-03-04 Monosol Rx, Llc Film compositions for delivery of actives
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US7425292B2 (en) * 2001-10-12 2008-09-16 Monosol Rx, Llc Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US7666337B2 (en) * 2002-04-11 2010-02-23 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
US7357891B2 (en) * 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US20060039958A1 (en) * 2003-05-28 2006-02-23 Monosolrx, Llc. Multi-layer films having uniform content
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20100021526A1 (en) * 2001-10-12 2010-01-28 Monosol Rx, Llc Ph modulated films for delivery of actives
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US7910641B2 (en) * 2001-10-12 2011-03-22 Monosol Rx, Llc PH modulated films for delivery of actives
WO2003030882A1 (en) * 2001-10-12 2003-04-17 Kosmos Pharma Thin film with non-self-aggregating uniform heterogeneity, process for their production and drug delivery systems made thereform
EP1317916B1 (en) * 2001-11-16 2010-10-27 Akzo Nobel Chemicals International B.V. Films containing modified starch
US8529807B2 (en) * 2002-01-17 2013-09-10 Lts Lohmann Therapie-Systeme Ag Method for neutralizing or recycling carrier materials for film-like coatings
ATE345784T1 (en) 2002-01-25 2006-12-15 Lohmann Therapie Syst Lts METHOD AND APPARATUS FOR PRODUCING WEB-SHAPED MATERIALS
US20030224090A1 (en) * 2002-02-11 2003-12-04 Edizone, Lc Snacks of orally soluble edible films
DE10207394B4 (en) * 2002-02-21 2007-03-29 Lts Lohmann Therapie-Systeme Ag Taste-masked oblate medicinal preparation
US8017150B2 (en) * 2002-04-11 2011-09-13 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
FR2840221B1 (en) * 2002-06-04 2006-01-13 Backert Marie Elisabeth Cuine POLYMERIC FILM CONTAINING "ACTIVE" TO BE RELEASED IN A LIQUID
US20030228264A1 (en) * 2002-06-06 2003-12-11 Perna Salvatore F. Dissolvable teeth whitening apparatus
AU2003268015A1 (en) * 2002-07-22 2004-02-09 Kosmos Pharma Packaging and dispensing of rapid dissolve dosage form
US7241411B2 (en) * 2002-08-23 2007-07-10 Acupac Packaging, Inc. Thin film strips
US6824829B2 (en) * 2002-08-23 2004-11-30 Acupac Packaging, Inc. Process for manufacturing thin film strips
DE10239101B4 (en) * 2002-08-27 2005-06-16 Scs Skin Care Systems Gmbh Patches for the administration of deodorants
GB2392446A (en) * 2002-09-02 2004-03-03 Reckitt Benckiser Nv Resin comprising water-soluble polymer and water-soluble filler
US8524200B2 (en) 2002-09-11 2013-09-03 The Procter & Gamble Company Tooth whitening products
US6916463B2 (en) * 2002-09-24 2005-07-12 The Procter & Gamble Company Oral products having an aesthetic layer
US20060205629A1 (en) 2002-10-30 2006-09-14 Reg Macquarrie Edible dissolving gelatin strips
US20040087467A1 (en) * 2002-10-30 2004-05-06 Reg Macquarrie Edible dissolving gelatin strips
US9561182B2 (en) * 2003-08-22 2017-02-07 Cure Pharmaceutical Corporation Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
US8999372B2 (en) * 2002-11-14 2015-04-07 Cure Pharmaceutical Corporation Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
US20040131662A1 (en) * 2003-11-12 2004-07-08 Davidson Robert S. Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
US20040191302A1 (en) 2003-03-28 2004-09-30 Davidson Robert S. Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
US20040096569A1 (en) * 2002-11-15 2004-05-20 Barkalow David G. Edible film products and methods of making same
US20040111275A1 (en) * 2002-11-15 2004-06-10 Kroll David B. Methods for marketing and generating revenue from edible thin films
WO2004050008A1 (en) 2002-12-02 2004-06-17 Kyukyu Pharmaceutical Co., Ltd. Process for producing edible orally administered agent of laminate film form and compression bonding apparatus
WO2004066986A1 (en) 2003-01-30 2004-08-12 Monosolrx Llc Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US20040156794A1 (en) * 2003-02-11 2004-08-12 Barkalow David G. Bioerodible and bioadhesive confectionery products and methods of making same
US20040180110A1 (en) 2003-03-14 2004-09-16 Atul Mistry Chewing gum and confectionery compositions containing an endothermic agent
CA2520380A1 (en) * 2003-03-26 2004-10-14 The Procter & Gamble Company Rapidly dissolving edible film compositions with cellulose film forming polymers
CN1764436A (en) * 2003-03-26 2006-04-26 宝洁公司 Rapidly dissolving edible film compositions with improved film strength and stability
BRPI0409336A (en) * 2003-04-14 2006-04-25 Fmc Corp release system comprising a thermoreversibly, homogeneous gel film, release system film, and process for preparing the release system thereof
EP1622595A1 (en) * 2003-05-02 2006-02-08 Warner-Lambert Company LLC Fast dissolving orally consumable films containing a modified starch for improved heat and moisture resistance
JP4795962B2 (en) 2003-05-28 2011-10-19 モノソル・アールエックス・エルエルシー Polyethylene oxide film and drug delivery system comprising the same
US20040241294A1 (en) * 2003-05-31 2004-12-02 Barabolak Roman M. Edible films including aspartame and methods of making same
JP4427981B2 (en) * 2003-06-26 2010-03-10 救急薬品工業株式会社 Method for punching film-like oral dosage form
DE10328942A1 (en) * 2003-06-27 2005-01-27 Lts Lohmann Therapie-Systeme Ag Transmucosal dosage forms with reduced mucous membrane irritation
DE10338544B4 (en) * 2003-08-19 2017-08-31 Janssen Pharmaceutica N.V. Buccal formulations of galanthamine and their applications
US7666396B2 (en) * 2003-09-11 2010-02-23 Kimberly-Clark Worldwide, Inc. Single-use moisturizing product
CA2543324C (en) 2003-10-24 2011-02-01 Adhesives Research, Inc. Rapidly disintegrating films for delivery of pharmaceutical or cosmetic agents
WO2005046363A2 (en) 2003-11-07 2005-05-26 U.S. Smokeless Tobacco Company Tobacco compositions
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
DE10354894A1 (en) * 2003-11-24 2005-07-07 Hf Arzneimittelforschung Gmbh Oral formulations of deoxypeganine and their applications
US20050136112A1 (en) * 2003-12-19 2005-06-23 Pediamed Pharmaceuticals, Inc. Oral medicament delivery system
DE102004002951A1 (en) * 2004-01-21 2005-08-11 Wella Ag Process for producing hair-setting products in film form
US20050222539A1 (en) * 2004-03-30 2005-10-06 Pediamed Pharmaceuticals, Inc. Automatic injection device
US7850987B2 (en) * 2004-04-08 2010-12-14 Micronutrient, Llc Nutrient composition(s) and system(s) for individualized, responsive dosing regimens
US7785619B2 (en) * 2004-04-08 2010-08-31 Micro Nutrient, Llc Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
WO2005097085A1 (en) * 2004-04-08 2005-10-20 Micro Nutrient, Llc Nutrient system for individualized responsive dosing regimens
US8728561B2 (en) 2004-04-15 2014-05-20 Living Cell Research Inc. Edible film compositions for processing of meat products
US7972589B2 (en) * 2004-05-17 2011-07-05 Akzo Nobel N.V. Hair fixative film
US9267167B2 (en) * 2004-06-28 2016-02-23 Becton, Dickinson And Company Dissolvable films and methods including the same
JP2008517108A (en) * 2004-10-18 2008-05-22 プランティック・テクノロジーズ・リミテッド Barrier film
FR2880262B1 (en) * 2005-01-03 2013-11-08 Oreal COSMETIC OR DERMATOLOGICAL ARTICLE COMPRISING A WATER-SOLUBLE SUPPORT
US20070110792A9 (en) * 2005-01-03 2007-05-17 L'oreal Cosmetic or dermatological article comprising a medium that is soluble in water
DE102005005633A1 (en) * 2005-02-08 2006-08-10 Wacker Polymer Systems Gmbh & Co. Kg Solvent-free producible dispersion containing a 1: 1 or 2: 1 cyclodextrin fragrance complex
US20090232911A1 (en) * 2005-03-25 2009-09-17 Yoichi Kato Use of sericin for improving feeling in use of denture
CA2606724A1 (en) * 2005-05-03 2006-11-09 Innozen, Inc. Edible film for transmucosal delivery of nutritional supplements
US20060275364A1 (en) * 2005-05-26 2006-12-07 Ahmed Salah U Flexible Solid Dosage Forms and Methods of Making and Using the Same
DE102005033943A1 (en) * 2005-07-20 2007-02-22 Hexal Ag Non-spitting, oral, fast-disintegrating film for a neuroleptic
DE102005058158A1 (en) * 2005-12-05 2007-06-06 Henkel Kgaa Foil for coloring keratinic fibers
US20070148248A1 (en) 2005-12-22 2007-06-28 Banner Pharmacaps, Inc. Gastric reflux resistant dosage forms
WO2007084587A2 (en) * 2006-01-20 2007-07-26 Monosol Rx, Llc Film lined pouch and method of manufacturing this pouch
RU2437657C2 (en) * 2006-03-16 2011-12-27 Новартис Аг Hard drug form containing active agent with disguised taste
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
JP4739452B2 (en) * 2006-09-20 2011-08-03 モノソル アールエックス リミテッド ライアビリティ カンパニー Eatable water-soluble film containing flavor enhancer to reduce foaming
CN101534799A (en) * 2006-09-29 2009-09-16 莫诺索尔克斯有限公司 Film embedded packaging and method of making same
WO2008040534A2 (en) 2006-10-02 2008-04-10 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Non-mucoadhesive film dosage forms
CN101616660A (en) * 2007-01-12 2009-12-30 莫诺索尔克斯有限公司 High dose film compositions and preparation method thereof
FR2912915B1 (en) * 2007-02-28 2012-11-16 Pf Medicament FAST DISINTEGRATING FILM FOR THE ORAL ADMINISTRATION OF ACTIVE SUBSTANCES.
US20080292683A1 (en) * 2007-05-24 2008-11-27 Monosolrx, Llc. Film shreds and delivery system incorporating same
FR2916635B1 (en) * 2007-05-30 2009-08-07 Backert Marie Elisabeth Cuine SOLID FORMULATIONS FOR ADMINISTRATION, PARENTLY PARENTAL, OF ACTI (S), IN THE FORM OF A FILM INTENDED TO BE DISSOLVED AND / OR DISPERSED IN A LIQUID PRODUCT
CA2689594A1 (en) 2007-06-07 2008-12-11 Sato Pharmaceutical Co., Ltd. Film preparation with rapidly dissolving property and flexibility
US8298583B2 (en) 2007-10-19 2012-10-30 Monosol Rx, Llc Film delivery system for tetrahydrolipstatin
WO2009073190A1 (en) * 2007-12-04 2009-06-11 Swedish Match North America, Inc. Fast dissolving films and coatings for controlled release of flavors, active pharmaceutical ingredients, food substances, and nicotine
DE102008023345B4 (en) 2008-05-13 2014-12-04 Lts Lohmann Therapie-Systeme Ag Film-like preparation with oily substances for oral administration
US9265779B2 (en) 2008-05-13 2016-02-23 Lts Lohmann Therapie-Systeme Ag Method of using a film-shaped preparation comprising oily substances for oral administration
US20100040727A1 (en) * 2008-08-18 2010-02-18 Monosol Rx, Llc Method for Improving Uniformity of Content in Edible Film Manufacturing
US8282954B2 (en) * 2008-12-15 2012-10-09 Monosol Rx, Llc Method for manufacturing edible film
US20100285130A1 (en) * 2009-05-06 2010-11-11 Monosol Rx, Llc Coating of complexed actives in film formulations
US20100297232A1 (en) * 2009-05-19 2010-11-25 Monosol Rx, Llc Ondansetron film compositions
TWI442937B (en) * 2009-05-26 2014-07-01 Colgate Palmolive Co Higher loading zinc-containing films
EA025054B1 (en) 2009-06-12 2016-11-30 Сайнэпсус Терапьютикс, Инк. Unit dosage form for sublingual administration comprising apomorphine particles for treating parkinson's disease or sexual dysfunction
US8475832B2 (en) * 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
EP2509631A4 (en) * 2009-12-10 2014-04-02 Monosol Rx Llc Ph sensitive compounds in taste masking within oral thin film strips
JP2013523634A (en) * 2010-03-26 2013-06-17 ダウ グローバル テクノロジーズ エルエルシー Melt extrusion film
CN103209681B (en) 2010-06-10 2017-05-24 Mida科技有限公司 Nanoparticle film delivery systems
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
US10238684B2 (en) 2010-11-18 2019-03-26 Foundational Biosystems, Llc Micro- and nano-quantity sleep enhancing nutrient composition and method of enhancing central nervous system protein clearance using same
PL2651357T3 (en) 2010-12-16 2020-08-24 Sunovion Pharmaceuticals Inc. Sublingual films
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
WO2014018075A1 (en) 2012-07-23 2014-01-30 Crayola, Llc Dissolvable films and methods of using the same
CA2888199C (en) 2012-10-17 2019-06-25 The Procter & Gamble Company Strip for the delivery of an oral care active and methods for applying oral care actives
US20140275194A1 (en) 2013-03-15 2014-09-18 Monosol Rx, Llc Films and drug delivery systems for rizatriptan
US9303918B2 (en) 2013-03-15 2016-04-05 Monosol Rx, Llc Process for drying a wet film with control of loss on drying
WO2014145699A1 (en) 2013-03-15 2014-09-18 New Jersey Institute Of Technology System and method for fabrication of uniform polymer films containing nano and micro particles via continuous drying process
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
JP2015154716A (en) * 2014-02-19 2015-08-27 日本合成化学工業株式会社 edible film
KR20220054908A (en) 2014-04-04 2022-05-03 인트라-셀룰라 써래피스, 인코퍼레이티드. Organic compounds
US20150366814A1 (en) 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients
CA3127926A1 (en) 2015-04-21 2016-10-27 Sunovion Pharmaceuticals Inc. Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
PT3407888T (en) 2016-01-26 2021-03-19 Intra Cellular Therapies Inc Organic compounds
PL3407889T3 (en) 2016-03-25 2021-11-22 Intra-Cellular Therapies, Inc. Organic compounds and their use in treating or preventing central nervous system disorders
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
CA3022840A1 (en) 2016-05-05 2017-11-09 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
US10906906B2 (en) 2016-12-29 2021-02-02 Intra-Cellular Therapies, Inc. Organic compounds
WO2018126140A1 (en) 2016-12-29 2018-07-05 Intra-Cellular Therapies, Inc. Organic compounds
JP7132939B2 (en) 2017-03-24 2022-09-07 イントラ-セルラー・セラピーズ・インコーポレイテッド Novel compositions and methods
US10238600B2 (en) 2017-04-13 2019-03-26 Richard C. Fuisz Package, system and methods for custody and control of drugs, and method and composition for making an oral soluble film, containing at least one active agent
US9901545B1 (en) 2017-04-13 2018-02-27 Richard C. Fuisz Method and composition for making an oral soluble film, containing at least one active agent
MX2021002321A (en) 2018-08-31 2021-04-28 Intra Cellular Therapies Inc Novel methods.
US11173114B1 (en) 2020-07-10 2021-11-16 Nova Thin Film Pharmaceuticals Llc Method and system for manufacturing and oral soluble films and oral soluble films made by thereby

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US352466A (en) * 1886-11-09 Geoege cheistopheb huttemeyee
BE637363A (en) *
US2852433A (en) * 1956-03-07 1958-09-16 Eastman Kodak Co Method of making enteric medicament compositions
DE2028224A1 (en) * 1969-06-10 1970-12-17 Solco Basel AG, Basel (Schweiz)j Orally applicable drug form
IN142428B (en) * 1974-07-05 1977-07-09 Schering Ag
US4136145A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
AU514195B2 (en) * 1975-12-15 1981-01-29 F. Hoffmann-La Roche & Co. Dosage form
ZA767136B (en) * 1975-12-15 1977-10-26 Hoffmann La Roche Novel dosage form
GB2009597B (en) * 1977-12-10 1982-06-23 Beecham Group Ltd Antacid compositions
US4683256A (en) * 1980-11-06 1987-07-28 Colorcon, Inc. Dry edible film coating composition, method and coating form
JPS6185315A (en) * 1984-10-04 1986-04-30 Teikoku Seiyaku Kk Sheet-like preparation
EP0219762B1 (en) * 1985-10-09 1990-12-27 Desitin Arzneimittel GmbH Process for the preparation of an administration and dosage for drugs, reagents or other active substances
DE3630603A1 (en) * 1986-09-09 1988-03-10 Desitin Arzneimittel Gmbh PHARMACEUTICAL AND DOSAGE FORM FOR MEDICINAL ACTIVE SUBSTANCES, REAGENTS OR THE LIKE, AND METHOD FOR THE PRODUCTION THEREOF
US4906488A (en) * 1987-05-01 1990-03-06 Arcade, Inc. Modification of permeant
DE3744009A1 (en) * 1987-12-24 1989-07-06 Fresenius Ag Pharmaceutical composition with a neutral flavour and containing one or more amino acids
US5077053A (en) * 1990-02-12 1991-12-31 Warner-Lambert Company Zein as a moisture barrier for sugarless edible compositions and method for preparing same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10301575B2 (en) 2015-04-14 2019-05-28 The Procter & Gamble Company Consumer product composition comprising a polyethylene glycol carrier with silicone particles dispersed therein
US10329519B2 (en) 2016-10-19 2019-06-25 The Procter & Gamble Company Consumer product composition comprising a polyethyleneglycol carrier, silicone conditioner, and particulate spacer material

Also Published As

Publication number Publication date
CA2044043A1 (en) 1991-12-08
EP0460588A1 (en) 1991-12-11
GR3018233T3 (en) 1996-02-29
ES2078994T3 (en) 1996-01-01
EP0460588B1 (en) 1995-08-30
ATE127016T1 (en) 1995-09-15
US5629003A (en) 1997-05-13
DE4018247C2 (en) 1992-05-14
DE59106348D1 (en) 1995-10-05
DE4018247A1 (en) 1991-12-12
DK0460588T3 (en) 1995-08-30
JPH07100186A (en) 1995-04-18
JP2559301B2 (en) 1996-12-04

Similar Documents

Publication Publication Date Title
CA2044043C (en) Process for the production of rapidly disintegrating sheet-like presentations
RU2297213C2 (en) Rapid degradation dosage form releasing active components into oral cavity or body cavities
RU2437648C2 (en) Foamed lozenge containing grafted copolymer of polyvinyl alcohol and polyethylene glycol
KR100493140B1 (en) Individually dosed foil-form presentation which decomposes rapidly on contact with liquid and contains an active substance, in particular an aromatic substance
AU609137B2 (en) Rapidly dissoluble medicinal dosage unit and method of manufacture
US6592887B2 (en) Water soluble film for oral administration with instant wettability
EP1008343A1 (en) Rapidly soluble filmy preparation
JP5719778B2 (en) Method for producing edible film
MXPA00003182A (en) Stable foam compositions.
US20030124178A1 (en) Soft, adherent, soluble oral patch
CA2339836C (en) Active ingredient support in the form of a film
US20070243238A1 (en) Treating mouth sores with patches adhered to teeth
AU777898B2 (en) Method for producing film-type dosage forms
CA2505126A1 (en) Soluble oral patch with collagen and interlaced active ingredients
Bagade et al. An updated overview on mucoadhesive buccal drug delivery system
CA2506712C (en) Rapidly-decomposing administrable form for releasing ingredients in the oral cavity or in bodily cavities
AU2005202270B2 (en) Rapidly Disintegrating Dosage form For Releasing Nicotine in the Oral Cavity or in Body Cavities
US20040126497A1 (en) Method for producing film-type dosage

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry